GeNeuro Aktie 30840308 / CH0308403085
0.03
EUR
0.00
EUR
-0.65
%
17:55:00
PAR
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
GeNeuro SA Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2022 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2021 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2020 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2019 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2018 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2017 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2016 | GeNeuro SA | 0.00 | 0.00 | EUR |
| 2015 | GeNeuro SA | - | - | EUR |
| 2014 | GeNeuro SA | - | - | EUR |
Zu diesem Datensatz liegen uns leider keine Daten vor.
GeNeuro SA Termine
| Unternehmen | Event | Datum |
|---|
GeNeuro SA vergangene Termine
| Terminart | Info | Datum |
|---|
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 32 | 0 | 0 | 17 | 17 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 29 | 12 | 7 | 8 | 10 |
| Summe Anlagevermögen | 1 | 1 | 2 | 3 | 3 |
| Summe Aktiva | 30 | 14 | 9 | 10 | 12 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 17 | 8 | 15 | 5 | 8 |
| Summe Eigenkapital | 13 | 5 | -5 | 5 | 5 |
| Summe Passiva | 30 | 14 | 9 | 10 | 12 |
Adresse
| 3, chemin du Pré-Fleur, 1228 Plan-les-Ouates | |
| Telefon | +41 (22) 552-48-00 |
| Fax | +41 (22) 794-50-86 |
| URL | http://www.geneuro.ch |
Management
|
Alois B. Lang
Chief Development Officer |
|
Anke Post
Chief Medical Officer |
|
Giacomo di Nepi
Independent Director |
|
Gordon S. Francis
Independent Director |
|
Hedi Ben Brahim
Independent Director |
|
Hervé Perron
Chief Scientific Officer |
|
Jesús Martin-Garcia
Chairman & Chief Executive Officer |
|
Michel Dubois
Independent Director |
|
Miguel Payró
Chief Financial Officer & Head-Human Resources |
|
Pascal Lemaire
Director |
|
Philippe Archinard
Independent Director |
|
Sandrine Flory
Director |